Lung Cancer: Pathophysiology, Diagnosis, and Nursing Care
This paper provides a comprehensive overview of lung cancer, covering current epidemiological statistics, risk factors, and key definitions for small cell and non-small cell lung cancer. It examines the normal anatomy of the lungs, clinical presentation, disease progression, and staging systems. The paper also surveys current diagnostic technologies — including fluorescence endoscopy and monoclonal antibody imaging — and approved treatment options such as Photofrin, Taxol, and Gemzar. A final section applies culturally sensitive nursing care by presenting NANDA-based nursing diagnoses tailored to Mexican Latino and Chinese immigrant patients, addressing coping, family communication, and spiritual distress.
- Introduction and Epidemiology: Lung cancer statistics, incidence rates, and risk factors
- Definitions and Staging: Cancer types defined and staging systems explained
- Pathophysiology and Disease Progression: Lung anatomy, clinical symptoms, and cancer progression
- Diagnosis: Current Tools and Techniques: Imaging, bronchoscopy, fluorescence, and antibody diagnostics
- Treatment Approaches: Surgery, chemotherapy, radiation, and FDA-approved drugs
- Culturally Sensitive Nursing Care: NANDA nursing diagnoses for immigrant patient populations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates clinical content (pathophysiology, staging, treatment) with applied nursing practice through NANDA-based diagnoses, demonstrating interdisciplinary thinking.
- Defines key terminology early, allowing the reader to follow technical discussions of cancer types and stages without confusion.
- Addresses cultural competence by tailoring nursing diagnoses to specific immigrant populations, acknowledging language barriers, family dynamics, and spiritual needs.
Key academic technique demonstrated
The paper effectively structures clinical information in a progression from general (epidemiology and definitions) to specific (individual patient nursing care plans), mirroring how clinical reasoning moves from population-level evidence to patient-centered intervention. This deductive organization is a hallmark of nursing and health sciences writing.
Structure breakdown
The paper opens with current lung cancer statistics and risk factors, then provides definitional background on cancer types and stages. It moves into pathophysiology, covering normal lung anatomy and disease progression, before surveying diagnostic tools and approved treatments. The paper concludes with a culturally sensitive nursing care section presenting structured NANDA nursing diagnoses for two distinct immigrant patient populations, each with short- and long-term goals.
Introduction and Epidemiology
Current Lung Cancer Statistics
Lung cancer is the leading cause of cancer death for both men and women, and the statistics for women have been increasing steadily since 1987, surpassing breast cancer as the leading cause of cancer death (Brown, 1999, p. 7). According to the American Cancer Society, more people die of lung cancer than of breast, prostate, and colon cancer combined.
In 2008, there were approximately 215,020 new cases of lung cancer (both small cell and non-small cell) in the United States: 114,690 among men and 100,330 among women. About 161,840 people died of this disease in 2008: 90,810 men and 71,030 women (American Cancer Society, "How Many People Will Get Non-Small Cell Lung Cancer?"). The incidence is therefore considered relatively high, and the rate of diagnosis increases with age and with other factors associated with lifestyle and environment.
Risk Factors
Risk factors for lung cancer include many environmental factors that increase risk but are not necessarily known to be independent causes of cancer. Smoking and secondhand smoke are the highest risk factors for lung cancer, but other environmental exposures also increase risk, including occupational exposure to inhaled carcinogens. Lung cancer does frequently occur among people with no known history of environmental exposure to carcinogens. Some occupational exposures, such as asbestos and coal dust, are associated with specific types of cancer that are diagnosed and treated differently.
Lung cancer is rare in people under the age of 45. The average lifetime chance that a man will develop lung cancer is about 1 in 13; for a woman, it is 1 in 16. These numbers include both smokers and non-smokers — for smokers the risk is much higher, while for non-smokers it is lower (American Cancer Society, "How Many People Will Get Non-Small Cell Lung Cancer?"). Lung cancer is a serious health threat in all nations but is more common in industrialized nations and in centers of industrial or agricultural activity.
Definitions and Staging
Key Definitions
Carcinoid Tumors: Tumors of the lungs that form masses but are usually well contained and can be cured by surgical intervention.
Lung Cancer: Any abnormally growing cells that occur primarily, or first, within the tissues of the lung and/or the lining of the lungs.
Non-Small Cell Lung Cancer: The most common form of lung cancer (approximately 75% of cases), in which cells form into larger tumors or masses during growth stages. These tumors can frequently be treated with surgery combined with drug and radiation therapy.
Small Cell Lung Cancer: A form of lung cancer in which cancer cells do not form discrete tumors or masses but instead spread across areas of the lung. This type is generally harder to detect and treat, as it has usually spread beyond the lungs and cannot be cured by surgery due to its diffuse nature.
Stages of Lung Cancer
There are two stages for small cell lung cancer. In the limited stage, the tumor is usually confined to one lung and the lymph nodes on the same side of the chest. In the extensive stage, the cancer has spread to the other lung, to lymph nodes on the other side of the chest, or to distant organs.
The stages of non-small cell lung cancer are as follows:
Occult Stage: Cancer can be detected in the patient's saliva, but tumors cannot be found in the lungs.
Stage 0: Cancer is localized in a few layers of cells and has not grown through the lung's top lining.
Stage I: The tumor is only in the lung and is surrounded by normal tissue.
Stage II: Cancer has spread to nearby lymph nodes.
Stage III: Cancer has spread to the chest wall or diaphragm near the lung, or to the lymph nodes in the mediastinum (the area that separates the two lungs), or to the lymph nodes on the other side of the chest or in the neck. This stage is divided into Stage IIIA, which can usually be operated on, and Stage IIIB, which usually cannot withstand surgery.
Stage IV: The cancer has spread to other parts of the body.
Recurrent: Cancer has returned after treatment (Brown, 1999, p. 7).
Create your account
Always verify citation format against your institution’s current style guide requirements.